Avantax Advisory Services’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-19,147
| Closed | -$397K | – | 2361 |
|
|
2025
Q1 | $397K | Sell |
19,147
-9,554
| -33% | -$198K | ﹤0.01% | 1660 |
|
|
2024
Q4 | $676K | Buy |
28,701
+702
| +3% | +$16.5K | ﹤0.01% | 1260 |
|
|
2024
Q3 | $717K | Buy |
27,999
+12,600
| +82% | +$323K | ﹤0.01% | 1196 |
|
|
2024
Q2 | $362K | Buy |
+15,399
| New | +$362K | ﹤0.01% | 1576 |
|
|
2023
Q3 | – | Sell |
-6,959
| Closed | -$237K | – | 1550 |
|
|
2023
Q2 | $237K | Sell |
6,959
-362
| -5% | -$12.3K | ﹤0.01% | 1313 |
|
|
2023
Q1 | $220K | Sell |
7,321
-1,271
| -15% | -$38.2K | ﹤0.01% | 1316 |
|
|
2022
Q4 | $243K | Sell |
8,592
-734
| -8% | -$20.7K | ﹤0.01% | 1219 |
|
|
2022
Q3 | $307K | Sell |
9,326
-1,557
| -14% | -$51.3K | ﹤0.01% | 994 |
|
|
2022
Q2 | $343K | Buy |
10,883
+231
| +2% | +$7.28K | 0.01% | 947 |
|
|
2022
Q1 | $493K | Buy |
10,652
+38
| +0.4% | +$1.76K | 0.01% | 795 |
|
|
2021
Q4 | $650K | Sell |
10,614
-4,238
| -29% | -$260K | 0.01% | 669 |
|
|
2021
Q3 | $1.11M | Sell |
14,852
-581
| -4% | -$43.5K | 0.02% | 460 |
|
|
2021
Q2 | $1.43M | Sell |
15,433
-1,501
| -9% | -$139K | 0.03% | 400 |
|
|
2021
Q1 | $1.5M | Buy |
16,934
+4,624
| +38% | +$410K | 0.03% | 351 |
|
|
2020
Q4 | $1.15M | Sell |
12,310
-13,828
| -53% | -$1.29M | 0.03% | 369 |
|
|
2020
Q3 | $1.67M | Buy |
26,138
+19,248
| +279% | +$1.23M | 0.03% | 401 |
|
|
2020
Q2 | $360K | Buy |
+6,890
| New | +$360K | 0.01% | 578 |
|